DEA schedule

Is Mounjaro a controlled substance?

Mounjaro contains tirzepatide. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Mounjaro (tirzepatide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tirzepatide is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Mounjaro?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Mounjaro
SourceWhat it lists
FDA NDC directory30 prescription listings from 2 labelers, none with a DEA schedule
DEA controlled substances listtirzepatide is not on the list

Mounjaro NDC listings

NDC listings for Mounjaro
NDCProductFormStrengthLabelerDEA schedule
0002-1471Mounjaroinjection, solution10 mg/.5mLEli Lilly and CompanyNone
0002-2340Mounjaroinjection, solution10 mg/.5mLEli Lilly and CompanyNone
50090-8021MOUNJAROinjection, solution10 mg/.5mLA-S Medication SolutionsNone
0002-1460Mounjaroinjection, solution12.5 mg/.5mLEli Lilly and CompanyNone
0002-2423Mounjaroinjection, solution12.5 mg/.5mLEli Lilly and CompanyNone
50090-8022MOUNJAROinjection, solution12.5 mg/.5mLA-S Medication SolutionsNone
0002-3444Mounjaro KwikPeninjection, solution12.5 mg/mLEli Lilly and CompanyNone
0002-4210Mounjaroinjection, solution12.5 mg/mLEli Lilly and CompanyNone
0002-1457Mounjaroinjection, solution15 mg/.5mLEli Lilly and CompanyNone
0002-3002Mounjaroinjection, solution15 mg/.5mLEli Lilly and CompanyNone
50090-8026MOUNJAROinjection, solution15 mg/.5mLA-S Medication SolutionsNone
0002-3433Mounjaro KwikPeninjection, solution16.7 mg/mLEli Lilly and CompanyNone
0002-4304Mounjaroinjection, solution16.7 mg/mLEli Lilly and CompanyNone
0002-1152Mounjaroinjection, solution2.5 mg/.5mLEli Lilly and CompanyNone
0002-1506Mounjaroinjection, solution2.5 mg/.5mLEli Lilly and CompanyNone
50090-8025MOUNJAROinjection, solution2.5 mg/.5mLA-S Medication SolutionsNone
0002-3422Mounjaro KwikPeninjection, solution20.8 mg/mLEli Lilly and CompanyNone
0002-4523Mounjaroinjection, solution20.8 mg/mLEli Lilly and CompanyNone
0002-3411Mounjaro KwikPeninjection, solution25 mg/mLEli Lilly and CompanyNone
0002-4612Mounjaroinjection, solution25 mg/mLEli Lilly and CompanyNone
0002-3466Mounjaro KwikPeninjection, solution4.17 mg/mLEli Lilly and CompanyNone
0002-4052Mounjaroinjection, solution4.17 mg/mLEli Lilly and CompanyNone
0002-1243Mounjaroinjection, solution5 mg/.5mLEli Lilly and CompanyNone
0002-1495Mounjaroinjection, solution5 mg/.5mLEli Lilly and CompanyNone
50090-8024MOUNJAROinjection, solution5 mg/.5mLA-S Medication SolutionsNone
0002-1484Mounjaroinjection, solution7.5 mg/.5mLEli Lilly and CompanyNone
0002-2214Mounjaroinjection, solution7.5 mg/.5mLEli Lilly and CompanyNone
50090-8023MOUNJAROinjection, solution7.5 mg/.5mLA-S Medication SolutionsNone
0002-3455Mounjaro KwikPeninjection, solution8.33 mg/mLEli Lilly and CompanyNone
0002-4103Mounjaroinjection, solution8.33 mg/mLEli Lilly and CompanyNone

Questions

Is Mounjaro a controlled substance?

No. Mounjaro (tirzepatide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tirzepatide is not on the DEA controlled substances list.

Is Mounjaro a narcotic?

No. Mounjaro (tirzepatide) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is GLP-1 Receptor Agonist and Glucose-dependent Insulinotropic Polypeptide Receptor Agonist.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Mounjaro

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing